换一批HIGH-RISK HISTOPATHOLOGICAL FEATURES OF RETINOBLASTOMA FOLLOWING PRIMARY ENUCLEATION: A Global Study Of 1,426 Patients From 5 Continents.
第一作者：
Swathi,Kaliki
第一单位：
The Operation Eyesight Institute for Eye Cancer, LV Prasad Eye Institute, Hyderabad, India.
作者：
Swathi,Kaliki [1]
;
Vijitha S,Vempuluru [1]
;
Komal Rajendra,Bakal [1]
;
Samten,Dorji [1]
;
Vishakha,Tanna [1]
;
Charlotte N,Shields [1]
;
Samuel J,Fallon [1]
;
Vishal,Raval [1]
;
Alia,Ahmad [2]
;
Asma,Mushtaq [2]
;
Mahvish,Hussain [2]
;
Yacoub A,Yousef [3]
;
Mona,Mohammad [3]
;
Soma Rani,Roy [4]
;
Fahmida,Huque [4]
;
Ushakova,Tatiana [5]
;
Serov,Yuri [6]
;
Polyakov,Vladimir [7]
;
Sandro Casavilca,Zambrano [8]
;
Sandra,Alarcón-León [8]
;
Cinthya,Valdiviezo-Zapata [8]
;
Maria,Vargas-Martorellet [8]
;
Cynthia,Gutierrez-Chira [8]
;
Mario,Buitrago [8]
;
Joana Sánchez,Ortiz [8]
;
Rosdali,Diaz-Coronado [9]
;
Devjyoti,Tripathy [10]
;
Suryasnata,Rath [10]
;
Gaurav,Patil [10]
;
Jesse L,Berry [11]
;
Sarah,Pike [11]
;
Brianne,Brown [11]
;
Mika,Tanabe [12]
;
Shahar,Frenkel [13]
;
Maya,Eiger-Moscovich [13]
;
Jacob,Pe'er [13]
;
Carol L,Shields [14]
;
Ralph C,Eagle [14]
;
Andrea,Laiton [14]
;
Ana Maria,Velasco [14]
;
Katherine,Vega [14]
;
Joseph,DeSimone [14]
;
Kavya Madhuri,Bejjanki [15]
;
Anasua Ganguly,Kapoor [15]
;
Anusha,Venkataraman [16]
;
Victoria,Bryant [16]
;
M Ashwin,Reddy [16]
;
Mandeep S,Sagoo [17]
;
G Baker,Hubbard [18]
;
Corrina P,Azarcon [18]
;
Thomas A,Olson [18]
;
Hans,Grossniklaus [18]
;
Olivia,Rolfe [19]
;
Sandra E,Staffieri [20]
;
Roderick,O'Day [21]
;
Anu A,Mathew [19]
;
James E,Elder [22]
;
John D,McKenzie [19]
;
Ido Didi,Fabian [23]
;
Rachel,Shemesh [23]
;
Vicktoria,Vishnevskia-Dai [23]
;
Mohammed Hasnat,Ali [1]
;
Saumya,Jakati [24]
;
Dilip K,Mishra [24]
;
Vijay Anand Reddy,Palkonda [1]
;
High-Risk Retinoblastoma Collaborative Study Group
作者单位：
The Operation Eyesight Institute for Eye Cancer, LV Prasad Eye Institute, Hyderabad, India.
[1]
Children Hospital, Lahore, Pakistan.
[2]
King Hussein Cancer Center, Amman, Jordan.
[3]
Chittagong Eye Infirmary and Training Complex, Chittagong, Bangladesh.
[4]
Department of Surgical Methods of Treatment with Chemotherapy No. 1 (Head and Neck Tumors), N. N. Blokhin National Medical Research Center of Oncology, Moscow, Russian Federation.;L. A. Durnov Department of Pediatric Oncology of the Russian Medical Academy of Continuing Professional Education, Moscow, Russian Federation.
[5]
Department of Surgical Methods of Treatment with Chemotherapy No. 1 (Head and Neck Tumors), N. N. Blokhin National Medical Research Center of Oncology, Moscow, Russian Federation.
[6]
Department of Surgical Methods of Treatment with Chemotherapy No. 1 (Head and Neck Tumors), N. N. Blokhin National Medical Research Center of Oncology, Moscow, Russian Federation.;L. A. Durnov Department of Pediatric Oncology of the Russian Medical Academy of Continuing Professional Education, Moscow, Russian Federation.;Department of ENT Diseases of the Faculty of Pediatrics of the Federal State Educational Institution of Higher Education of N. I. Pirogov Russian National Research Medical University, Moscow, Russian Federation.
[7]
Pediatric Oncology Department, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.
[8]
Pediatric Oncology Department, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.;Universidad Peruana Cayetano Heredia, Lima, Peru.
[9]
LV Prasad Eye Institute, Bhubaneswar, India.
[10]
Children's Hospital Los Angeles and USC Roski Eye Institute, Los Angeles, California.;Keck School of Medicine, Los Angeles, California.
[11]
Kyushu University, Fukuoka, Japan.
[12]
Hadassah Medical Center, Jerusalem, Israel.
[13]
Ocular Oncology Service, Wills Eye Hospital, Philadelphia, Pennsylvania.
[14]
LV Prasad Eye Institute, Vijayawada, India.
[15]
Royal London Hospital, Barts Health NHS Trust, London, United Kingdom.
[16]
Royal London Hospital, Barts Health NHS Trust, London, United Kingdom.;Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom.;NIHR Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital, London, United Kingdom.;UCL Institute of Ophthalmology, London, United Kingdom.
[17]
Emory University School of Medicine, Georgia, Atlanta.
[18]
Royal Children's Hospital, Victoria Australia.
[19]
Royal Children's Hospital, Victoria Australia.;Murdoch Children's Research Institute, Melbourne, Australia.;Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Australia.;University of Melbourne, Melbourne, Australia.
[20]
Royal Children's Hospital, Victoria Australia.;Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Australia.
[21]
Royal Children's Hospital, Victoria Australia.;University of Melbourne, Melbourne, Australia.
[22]
Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel; and.
[23]
Ophthalmic Pathology Laboratory, LV Prasad Eye Institute, Hyderabad, India.
[24]
医学主题词
人类(Humans);视网膜母细胞瘤(Retinoblastoma);眼球摘除术(Eye Enucleation);回顾性研究(Retrospective Studies);视网膜肿瘤(Retinal Neoplasms);男(雄)性(Male);女(雌)性(Female);儿童, 学龄前(Child, Preschool);婴儿(Infant);儿童(Child);危险因素(Risk Factors);北美洲(North America);随访研究(Follow-Up Studies);肿瘤侵润(Neoplasm Invasiveness);欧洲(Europe)
DOI
10.1097/IAE.0000000000004250
PMID
39151183
发布时间
2025-06-05
- 浏览1
Retina (Philadelphia, Pa.)
Retina (Philadelphia, Pa.)
2105-2115页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
